"Post-TIPS HE [hepatic encephalopathy] may reflect the patients' overall vulnerability leading to an increased risk for complications and thus explaining the overall poorer prognosis of these patients ...

Rifaximin improves the gut microenvironment by reducing the abundance of harmful bacteria while increasing probiotic bacteria. It inhibits the translocation of bacteria from the mouth to the intestine ...

In a clinical guideline issued by the American College of Gastroenterology and published in the March issue of the American Journal of Gastroenterology, recommendations are presented for the diagnosis ...

From January 2008 to September 2009, consecutive cirrhotic patients (age 18–70 years) who never had encephalopathy were enrolled. Cirrhosis was diagnosed on a clinical basis involving laboratory tests ...

When the liver fails, toxins - such as ammonia - that should be filtered from the blood build up and reach the brain.

Please provide your email address to receive an email when new articles are posted on . FMT demonstrated a favorable safety profile with no related adverse or serious adverse events. Hepatic ...

Roughly half as many patients with cirrhosis in remission from overt hepatic encephalopathy (OHE) experienced a breakthrough episode with rifaximin monotherapy compared with lactulose monotherapy, a ...

Hepatic encephalopathy (HE) is a condition that can affect the brain in people who have chronic liver disease. It happens when a damaged liver cannot effectively filter ammonia and other toxins out of ...

Please provide your email address to receive an email when new articles are posted on . Hepatic encephalopathy can have substantial negative impact on patients, family and health care systems.

LAVAL, QC / ACCESS Newswire / May 6, 2025 / Bausch Health Companies Inc. (BHC), a global, diversified pharmaceutical company, and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), ...

(RTTNews) - Bausch Health Companies Inc. (BHC.TO) on Friday said its Phase 3 RED-C clinical program evaluating amorphous rifaximin solid soluble dispersion (SSD) in adults with liver cirrhosis for the ...